A Study of Elenestinib in Healthy Adult Female Participants

Recruiting

Phase 1

Elenestinib with Midazolam & Levonorgestrel/Ethinyl EstradiolA Study of Elenestinib in Healthy Adult Female Participants

Sponsor:

Blueprint Medicines Corporation

Code:

NCT07388511

Conditions

Healthy Participants

Eligibility Criteria

Sex: Female

Age: 18 - 65

Healthy Volunteers: Accepted

Interventions

Elenestinib

Midazolam

Levonorgestrel/Ethinyl Estradiol

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-12. This information was provided to ClinicalTrials.gov by Blueprint Medicines Corporation on 2026-02-05.